Michael Klowden's most recent trade in NKGen Biotech Inc was a trade of 500,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NKGen Biotech Inc | Michael Klowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| NKGen Biotech Inc | Michael Klowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| NKGen Biotech Inc | Michael Klowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 300,000 | 300,000 | - | - | Stock Option (right to buy) |